MarketsandMarkets

Infectious Disease and Molecular Diagnostics Conference

19th - 20th October 2023

Boston, USA

The Diagnostics sector has emerged as a prominent game changer in healthcare, because of many technological advancements taking place within the field. As diagnostics is a key to making treatment decisions, it needs to be quicker, more precise, and more accurate.

MarketsandMarkets is extremely delighted to announce it's Infectious Disease Diagnostics and Molecular Diagnostics Conference USA Edition scheduled to be held on 19th - 20th October 2023 in Boston. The conference is hand crafted to platform new diagnostics insights, holding discussions on trending technologies along with its latest applications, indicating the challenges in diagnostics area covering, diagnostic setting, sample processing, regulations, validations, high technology cost, challenges involved in blood – transfusion technology, what needs to happen to facilitate better healthcare throughout the world, how vaccines work and their side-effects, challenges associated with test kits, issues with accuracy & the results.

WHAT TO EXPECT

Molecular Diagnostics

  • Integrated Host-Microbe Plasma Metagenomics for Precision Diagnosis of Sepsis
  • Liquid Biopsies and Blood Based Molecular Diagnostics
  • COVID from different perspectives
  • Utility of Microbial Metagenomics in a Cancer Patient Population
  • Quality Management in Molecular Diagnostics
  • NGS based Molecular Diagnostics
  • Molecular Diagnostics in Infectious Diseases
  • Molecular Diagnostics in preventive medicine
  • Future Molecular Diagnostics and New Diagnostic Technologies
  • Molecular Diagnostics in Laboratory Medicine and Genetics

Infectious Disease Diagnostics

  • Clinical Metagenomic Sequencing for Diagnosis of Infections
  • Use of POCT to Improve Outpatient Antibiotic Use
  • Emerging infectious diseases
  • Portable point-of-care testing systems and increasing global access to care
  • Host Response-Based Diagnostics for Infectious Disease
  • Evaluating non-invasive screening strategies and Point of care testing for liver diseases
  • The impact of the covid-19 pandemic on diagnostic innovation for infectious disease
  • Multiplex Blood-Borne Pathogen Detection
  • Food & Water-Borne Infectious Diseases
  • Advances in testing and multiplexing

  • Learn about innovative devices and procedures for effective diagnostics
  • Meet global heads of infectious disease and molecular diagnostics from the industry and Academics
  • Participate in discussions with experts on how technology implementation can be improved
  • Attracting and retaining world-class talent
  • Resolve common R&D challenges
  • Discover the latest technology implementations in the industry
  • Discover best-in-class solutions during the workshop sessions
  • Interactive panel discussions
  • 120+ Professionals Attending
  • Case studies presented from leading technology collaborations

Hospitals/Universities/Labs

  • Hospitals - Department of infectious diseases. Department of hematology, Department of Genomics, Diagnostics Department, Molecular Biology, Molecular Genetics
  • Hospital Designations - Senior scientist, scientist, Microbiologist, biologists, pathologist, General
  • Practitioners, Lab managers, Lab directors, medical directors, POCT coordinators
  • Universities Designations- Professors, Researchers, Associate professors, Deans, Senior Professors
  • Hospital Laboratories Designations- Pathologists, Lab managers, Lab Directors, Clinicians
  • Pharma/Therapeutics Designation- CEO, COO, Senior scientist, Research scientist, POCT specialist

 

CONFERENCE AGENDA

Registration

08:15 - 08:55

Welcome note from MarketsandMarkets

08:55 - 09:00

Opening Remarks from the Chairperson

TBA, Senior Representative

TBA, Senior Representative, Co-Diagnostics, Inc,

09:00 - 09:10

IMPLEMENTATION AND INTERPRETATION OF ADVANCED MOLECULAR DIAGNOSTICS

Keynote Presentation - HIV, AIDS, STD are the most transmitted diseases in these days. Vaccine Pharmacovigilance: Lessons Learned from the COVID-19 Pandemic

Jamar Shaw

Jamar Shaw, Sr. Infection Control Practitioner , Emory Healthcare

09:10 - 09:40

Molecular Diagnostics in Laboratory Medicine and Genetics

Michael Linden

Michael Linden, Medical Director, Wake Forest Baptist Health Molecular Diagnostics Laboratory Immunohistochemistry

09:40 - 10:10

Managing Bacterial Antibiotic Resistance on Earth and Space

A. C. Matin

A. C. Matin, Professor of Microbiology & Immunology, Emeritus Stanford University School of Medicine

10:10 - 10:40

Morning Refreshments and Poster Presentation | One-to-One Networking Meetings

10:40 - 11:30

Food and Water Borne Infectious Diseases

11:30 - 12:00

REIMAGING DIAGNOSTICS WITH SMART TECHNOLOGIES

Syndromic testing in clinical microbiology: is it worth the money?

12:00 - 12:30

Use of POCT to Improve Outpatient Antibiotic Use

12:30 - 13:00

Lunch and Poster Presentation | One-on-One Networking Meetings

13:00 - 14:00

Clinical Metagenomic Sequencing for Diagnosis of Infections

14:00 - 14:30

TAILORING MODEL’S AND ADVANCEMENTS UNDER INFECTIOUS DISEASE DIAGNOSTICS POINT OF CARE TESTING

Evaluating non-invasive screening strategies and Point of care testing for liver diseases

14:30 - 15:00

Afternoon Refreshments and Poster Presentation | One-to-One Networking Meetings

15:00 - 15:50

PROMISING DIAGNOSTIC TECHNIQUES IN THE ERA OF CONSOLIDATION

Flu Testing - Validation Process and The Revalidation Post Flu Season

15:50 - 16:20

T-Cell Homing in Virus Infection

16:20 - 16:50

Electrochemical Biosensors and Lab-on-Chip Devices for Molecular and Infectious Diseases Diagnosis

16:50 - 17:20

Closing Remarks from the Chairperson

TBA, Senior Representative

TBA, Senior Representative, Co-Diagnostics, Inc,

17:20 - 17:20

Drinks Reception & Networking

17:20 - 17:20

End of Day 1

17:20 - 17:20

Registration

08:15 - 08:55

Welcome note from MarketsandMarkets

08:55 - 09:00

Host Response-Based Diagnostics for Infectious Disease

09:00 - 09:10

FUTURE MOLECULAR DIAGNOSTICS AND NEW DIAGNOSTIC TECHNOLOGIES

Keynote Presentation: Integrated Host-Microbe Plasma Metagenomics for Precision Diagnosis of Sepsis

09:10 - 09:40

Molecular Diagnostics in Infectious Diseases

09:40 - 10:10

Solution Provider Presentation

10:10 - 10:40

Morning Refreshments and Poster Presentation | One-to-One Networking Meetings

10:40 - 11:30

Solution Provider Presentation

11:30 - 12:00

Utility of Microbial Metagenomics in a Cancer Patient Population

12:00 - 12:30

Quality Management in Molecular Diagnostics

12:30 - 13:00

Lunch and Poster Presentation | One-on-One Networking Meetings

13:00 - 14:00

Molecular Diagnostics in preventive medicine

14:00 - 14:30

SHAPING THE POINT OF CARE ERA WITH BEST TOOLS AND METHODOLOGIES

Antimicrobial Susceptibility Testing

14:30 - 15:00

Metagenomics-Based Diagnostics

15:00 - 15:30

Multiplex respiratory virus testing

15:30 - 16:00

Host response vs. pathogen detection

16:00 - 16:30

Rapid infectious disease diagnostics and community surveillance

16:30 - 17:00

Closing Remarks from the Chairperson

TBA, Senior Representative

TBA, Senior Representative, Co-Diagnostics, Inc,

17:00 - 17:20

END OF CONFERENCE

17:20 - 17:20

ENQUIRE NOW

CONFERENCE SPEAKERS

ADVISORS

Jamar Shaw

Jamar Shaw

Sr. Infection Control Practitioner , Emory Healthcare

SPEAKERS

Jamar Shaw

Jamar Shaw

Sr. Infection Control Practitioner , Emory Healthcare

Seth D. Crosby

Seth D. Crosby

Director, Research Collaborations, Washington University School of Medicine

Paulina Predko

Paulina Predko

Researcher Scientist, Brigham and Women's Hospital

Shailesh Agarwal

Shailesh Agarwal

Assistant Professor of Surgery, Harvard Medical School, Partner, Mainspring Venture Partners

Jenna Rivers

Jenna Rivers

Infection Preventionist, Moffitt Cancer Center

Nir Ben Chetrit

Nir Ben Chetrit

Research Associate, Weill Cornell Medicine

Ryan Mansell

Ryan Mansell

Research Technician, Weill Cornell Medicine

Michael Linden

Michael Linden

Medical Director, Wake Forest Baptist Health Molecular Diagnostics Laboratory Immunohistochemistry

A. C. Matin

A. C. Matin

Professor of Microbiology & Immunology, Emeritus Stanford University School of Medicine

Kanupriya Kusumakar

Kanupriya Kusumakar

Research Scientist, Brigham and Women’s Hospital

Keigo Machida

Keigo Machida

Associate Professor of Molecular Microbiology & Immunology, University of Southern California

SPONSORS

Co-Diagnostics Inc.

PARTNERS

LOCATION

Venue

Boston, USA

PAST EVENT GALLERY